Aspartame as a Preventive Agent of Chronic Toxic Effects of Ochratoxin a in Experimental Animals

References

• van der Merwe K. J., Steyn P. S., Fourie L. Mycotoxins. Part II The constitution of ochratoxins A, B and C, metabolites of Aspergillus ochraceus Wilh. J. Chem. Soc. 1968; 7083
   Google Scholar
• Krogh P. Ochratoxins. Mycotoxins in human and animal health, J. V. Rodricks, C. W. Hesseltine, M. A. Mehlman. Pathotox, Forest Park South, Ill. 1977; 489
   Google Scholar
• Krogh P. Mycotoxins in food, P. Krogh. Academic Press, Cambridge 1987; 1
   Google Scholar
• Micco C., Ambruzzi M. A., Miraglia M., Brera C., Onori R., Benelli L. Contamination of human milk with ochratoxin A. Mycotoxins. Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky, H. Bartsch. IARC Scientific publication. 1991; Vol. 115: 105
   Google Scholar
• Miraglia M., Brera C., Corneli S., De Dominicis R. Ochratoxin A in Italy: status of knowledge and perspectives. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. INSERM/John Libbey Eurotext Ltd. 1993; Vol. 231: 129
   Google Scholar
• Castegnaro M., Bartsch H., Béréziat J. C., Arvela P., Michelon J., Broussolle L. Polymorphic ochratoxin A hydroxylation in rats strains phenotyped as poor and extensive metabolizers of debrisoquine. Xenibiotica 1989; 19: 225
   PubMed Web of Science ®Google Scholar
• Petkova-Bocharova T., Chernozemsky I., Castegnaro M. Ochratoxin A in relation to endemic nephropathy and urinary system tumours in Bulgaria. Food Addit. Contam. 1988; 5: 299
   PubMedGoogle Scholar
• Olsen J. H., Hald B., Thorup I., Carstensen B. Distribution in Denmark of porcine nephropathy and chronic disorders of the urinary tract in humans. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castagnero, G. Dirheimer. INSERM/ John Libbey Eurotext Ltd. 1993; Vol. 231: 209
   Google Scholar
• Bacha H., Maaroufi K., Achour A., Hammami M., Ellouz F., Creppy E. E. Ochratoxines et ochratoxicoses humaines en Tunisie. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. INSERM/John Libbey Eurotext ltd. 1993; Vol. 231: 111
   Google Scholar
• Achour A., El-May M., Bacha H., Hammami M., Maaroufi K., Creppy E. E. Néphropathies interstitielles chroniques. Approches cliniques et étiologiques: ochratoxine A. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. INSERM/John Libbey Eurotext ltd. 1993; Vol. 231: 227
   Google Scholar
• Haubeck H. D., Lorkowski G., Kolsch E., Röschenthaler R. Immunosuppression by ochratoxin A and its prevention by phenylalanine. Appl. Environ. Microbiol. 1981; 41: 1040
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Stormer F. C., Röschenthaler R., Dirheimer G. Effects of two metabolites of ochratoxin A, [4R]-4-hydroxyochratoxin A and ochratoxin alpha, on the immune response in mice. Infect, Immun. 1983; 39: 1015
   PubMed Web of Science ®Google Scholar
• Lea T., Stein K., Stormer F. C. Mechanism of ochratoxin A-induced immunosuppression. Mycopathology 1989; 107: 153
   PubMed Web of Science ®Google Scholar
• Stormer F. C., Lea T. Effects of ochratoxin A upon early and late events in human T-cell proliferation. Toxicology 1995; 95: 45
   PubMedGoogle Scholar
• Creppy E. E., Kane A., Dirheimer G., Lafarge-Frayssinet C., Mousset S., Frayssinet C. Genotoxicity of ochratoxin A in mice: DNA single-strand breaks evaluation in spleen, liver and kidney. Toxicol. Lett. 1985; 28: 29
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A., Grosse Y., Kane A., Creppy E. E., Dirheimer G. Differential DNA-adduct formation and disappearance in three mice tissues after treatment by the mycotoxin ochratoxin A. Mutation Res. 1993; 289: 265
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A., Grosse Y., Kane A., Gharbi A., Baudrimont I., Obrecht S. M., Creppy E. E., Dirheimer G. Is the oxidative pathway implicated in the genotoxicity of ochratoxin A. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. John Libbey Eurotext INSERM. 1993; Vol. 231: 177
   Google Scholar
• Pfohl-Leszkowicz A., Grosse Y., Obrecht S. M., Kane A., Castegnaro M., Creppy E. E., Dirheimer G. Preponderance of DNA-adducts in kidney after ochratoxin A. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. John Libbey Eurotext INSERM. 1993; Vol. 231: 199
   Google Scholar
• Gilani S. H., Bancroft J., Reily M. Teratogenicity of ochratoxin A in chick embryos. Toxicol. Appl. Pharmacol. 1978; 46: 543
   PubMed Web of Science ®Google Scholar
• Hayes A. W., Hood R. D., Lee H. L. Teratogenic effects of ochratoxin A in mice. Teratology 1974; 9: 93
   PubMedGoogle Scholar
• Arora R. G., Frölen H. Interference of mycotoxins with prenatal development of the mouse. Ochratoxin A induced teratogenic effects in relation to the dose and stage of gestation. Acta Vet Scand. 1981; 22: 535
   PubMedGoogle Scholar
• Mayura K., Stein A. F., Berndt W. O., Phillips T. D. Teratogenic effects of ochratoxin A in rats with impaired renal function. Toxicology 1984; 32: 277
   PubMed Web of Science ®Google Scholar
• Mayura K., Edwards J. F., Maull E. A., Phillips T. D. The effects of ochratoxin A on post implantation rat embryos in culture. Arch. Environ. Contam. Toxicol. 1989; 18: 411
   Google Scholar
• Pitout M. J. The effect of ochratoxin A on glycogen storage in the rat liver. Toxicol. Appl. Pharmacol. 1968; 13: 299
   PubMed Web of Science ®Google Scholar
• Pohland A. E., Nesheim S., Friedman L. Ochratoxin A: A review. Pure and Appl. Chem. 1992; vol. 64(7)1029
   Google Scholar
• Stormer F. C. Ochratoxin A-A mycotoxin of concern. Handbook of applied Mycology. Mycotoxins in Ecological Systems, D. Bhatnagar, E. B. Lillehoj, D. K. Arora. M. Dekker, Inc. 1992; Vol. 5: 403
   Google Scholar
• Creppy E., Kern D., Steyn P. S., Vlegaar R., Röschenthaler R., Dirheimer G. Comparative study of the effect of ochratoxin analogues on yeast animoacyl-tRNA synthetases and on the growth and protein synthesis of hepatoma cells. Toxicol. Lett. 1983; 19: 217
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Stormer F. C., Kern D., Röschenthaler R., Dirheimer G. Effects of ochratoxin A metabolites on yeast phenylalanyl-tRNA synthetase and in vitro protein synthesis of hepatoma cells. Chem. Biol. Interact. 1983; 47: 239
   PubMed Web of Science ®Google Scholar
• Föllmann W., Hillebrand I. E., Creppy E. E., Bolt H. M. Sister chromatid exchange frequency in culture isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha. Arch. Toxicol. 1995; 14: 34
   Google Scholar
• Bauer J., Gareis M. Ochratoxin A in der Nahrungsmittelkette. Z. Veterinärmed. B. 1987; 34: 613
   PubMedGoogle Scholar
• Breitholtz A., Olsen M., Dahlback A., Hult K. Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit Contam. 1991; 183: 192
   Google Scholar
• Creppy E. E., Betbeder A. M., Gharbi A., Counord J., Castegnaro M., Bartsch H., Moncharmont P., Fouillet B., Chambon P., Dirheimer G. Human ochratoxicosis in France. Mycotoxins. Endemic Nephropathy and Renal Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. Chernozemsky, H. Bartsch. IARC scientific publication, Lyon 1991; Vol 115: 1
   Google Scholar
• Creppy E. E., Castegnaro M., Grosse Y., Meriaux J., Manier C., Moncharmont P., Waller C. Etude de l'ochratoxicose humaine dans trois régions de France: Alsace, Aquitaine et Région Rhône-Alpes. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. INSERM/John Libbey Eurotext Itd. 1993; Vol. 231: 147
   Google Scholar
• Kuiper-Goodman T., Scott P. M. Risk assessment of the mycotoxin ochratoxin A. Biomed and Environ. Sci. 1989; 2: 179
   PubMedGoogle Scholar
• Kawamura O., Maki S., Sato S., Ueno Y. Ochratoxin A in livestock and human sera in Japan quantified by a sensitive ELISA. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. John Libbey Eurotext INSERM. 1993; Vol 231: 159
   Google Scholar
• Hadidane R., Bacha H., Creppy E. E., Hammami M., Ellouz F., Dirheimer G. Isolation and structure determination of natural analogues of the mycotoxin ochratoxin A produced by Aspergillus ochraceus. Toxicology 1992; 76: 233
   PubMed Web of Science ®Google Scholar
• Heller K., Röschenthaler R. Inhibition of protein synthesis in streptococcus faecalis by ochratoxin A. Can. J. Microbiol. 1978; 24: 466
   Web of Science ®Google Scholar
• Bunge L, Dirheimer G., Röschenthaler R. In vitro and in vivo inhibition of protein synthesis in Bacillus stearothermophilus by ochratoxin A. Biochem. Biophys. Res. Commun. 1978; 83: 398
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Lugnier A. A.J., Fasiolo F., Heller K., Röschenthaler R., Dirheimer G. in vitro inhibition of yeast phenylalanyl-tRNA synthetase by ochratoxin A. Chem. Biol. Interact. 1979; 24: 257
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Lugnier A. A.J., Beck G., Röschenthaler R., Dirheimer G. Action of ochratoxin A on cultured hepatoma cells-Reversion of inhibition by phenylalanine. FEBS Lett. 1979; 104: 287
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Chakor K., Fisher M. J., Dirheimer G. The mycotoxin ochratoxin A is a substrate for phenylalanine hydroxylase in isolated rat hepatocytes and in vivo. Arch. Toxicol. 1990; 64: 279
   PubMedGoogle Scholar
• Meisner H., Chang S. Ochratoxin A, an inhibitor of mitochondrial transport system. Biochemistry 1974; 13: 2795
   PubMed Web of Science ®Google Scholar
• Wei Y. H., Lu C. Y., Lin T. N., Wei R. D. Effect of ochratoxin A on rat liver mitochondrial respiration and oxidative phosphorylation. Toxicology 1985; 36: 119
   PubMed Web of Science ®Google Scholar
• Yong S., Albassam M., Prior M. Protective effect of sodium bicarbonate on murine ochratoxicosis. J. Environ. Sci. Health B. 1987; 22: 455
   PubMed Web of Science ®Google Scholar
• Belmadani A., Betbeder A-M., Tramu G., Creppy E. E. Effects of ochratoxin A in central nervous system of rats fed subchronically: variation of free amino acids and prevention by a structural analogue. Toxicology 1996, submitted for publication
   Google Scholar
• Roth A., Chakor K., Creppy E. E., Kane A., Röschenthaler R., Dirheimer G. Evidence for an enterohepatic circulation of ochratoxin A in mice. Toxicology 1988; 48: 293
   PubMed Web of Science ®Google Scholar
• Madhyastha M. S., Frohlich A. A., Marquardt R. R. Effect of dietary cholestyramine on the elimination pattern of ochratoxin A in rats. Fd. Chem. Toxic. 1992; 30: 709
   PubMed Web of Science ®Google Scholar
• Baudrimont I., Betbeder A. M., Gharbi A., Pfohl-Leszkowicz A., Dirheimer G., Creppy E. E. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronical administration of ochratoxin A in rats. Toxicology 1994; 89: 101
   PubMed Web of Science ®Google Scholar
• Pfohl-Leszkowicz A, Obrecht S., Grosse Y., Dirheimer G. Involvement of antioxydants and inhibitors of glutathione conjugaison in ochratoxin A genotoxicity in mice and kidney. Toxocol. Letters. suppl. 1994a; 74: 64
   Google Scholar
• Kumari D., Sinha S. P. Effect of retinol on ochratoxin-produced genotoxicity in mice. Fd. Chem. Toxic. 1994; 32: 471
   PubMed Web of Science ®Google Scholar
• Bose S., Sinha S. P. Modulation of ochratoxin A-produced genotoxicity in mice by vitamin C. Food. Chem. Toxicol. 1994; 32: 533
   PubMed Web of Science ®Google Scholar
• Baudrimont I., Murn M., Betbeder A. M., Guilcher J., Creppy E. E. Effect of piroxicam on the nephrotoxicity induced by ochratoxin A in rats. Toxicology 1995; 95: 147
   Google Scholar
• Creppy E. E., Schlegel M., Röschenthaler R., Dirheimer G. Phenylalanine prevents acute poisoning by ochratoxin A in mice. Toxicol. Lett. 1980; 6: 77
   PubMed Web of Science ®Google Scholar
• Creppy E. E., Röschenthaler R., Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem. Toxicol. 1984; 22: 883
   PubMed Web of Science ®Google Scholar
• Kane A. Intoxication subchronique par l'ochratoxine A, Mycotoxine contaminant les aliments: effets néphrotoxiques et génotoxiques. Thèse de doctorat de l'Université Louis Pasteur, Strasbourg 1986
   Google Scholar
• Kane A., Creppy E. E., Roth A., Röschenthaler R., Dirheimer G. Distribution of the [3H]-label from low doses of radioactive ochratoxin A ingested by rats, and evidence for DNA single-strand breaks caused in liver and kidneys. Arch. Toxicol. 1986a; 58: 219
   PubMed Web of Science ®Google Scholar
• Kane A., Creppy E. E., Röschenthaler R., Dirheimer G. Changes in urinary and renal tubular enzymes caused by subchronic administration of ochratoxin A in rats. Toxicology 1986; 42: 233
   PubMedGoogle Scholar
• Chakor K, Creppy E. E., Dirheimer G. In vivo studies on the relationship between hepatic metabolism and toxicity of ochratoxin A. Arch. Toxicol. Suppl. 1988; 12: 201
   Google Scholar
• Moroi K., Suzuki S., Kuga T., Yamazaki M., Kanisawa M. Reduction of ochratoxin A toxicity in mice treated with phenylalanine and phenobarbital. Toxicol. Lett. 1985; 25: 1
   PubMed Web of Science ®Google Scholar
• Suzuki S., Moroi K., Kanisawa M., Satoh T. Effect of drug metabolizing enzyme inducers on carcinogenesis and toxicity of ochratoxin A in mice. Toxicol. Lett. Suppl. 1986; 31: 206
   Google Scholar
• Fink-Gremmels J., Blom M., Woutersen F. In vitro investigations on ochratoxin A metabolism. Human ochratoxicosis and its pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. John Libbey Eurotext INSERM. 1993; Vol. 231: 67
   Google Scholar
• Ranney R. E., Oppermann J. A., Muldoon E. Comparative metabolism of Aspartame in experimental animals and humans. J. Toxicol. Environ. Health. 1976; 2: 441
   PubMed Web of Science ®Google Scholar
• Moller S. E. Effect of Aspartame and Protein, Administered in Phenylalanine-Equivalent Doses, on Plasma Neutral Amino Acids, Aspartate, Insulin and Glucose in Man Pharmacology. Toxicology 1991; 68: 408
   Google Scholar